Home  |  Contact

UniProtKB/Swiss-Prot P20807: Variant p.Gln486Glu

Calpain-3
Gene: CAPN3
Variant information

Variant position:  486
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glutamine (Q) to Glutamate (E) at position 486 (Q486E, p.Gln486Glu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (Q) to medium size and acidic (E)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In LGMDR1.
Any additional useful information about the variant.



Sequence information

Variant position:  486
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  821
The length of the canonical sequence.

Location on the sequence:   EEDDDPDDSEVICSFLVALM  Q KNRRKDRKLGASLFTIGFAI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EEDDDPDDSEVICSFLVALMQKNRRKDRKLGASLFTIGFAI

Mouse                         EEDDDPEDSEVICSFLVALMQKNRRKDRKLGANLFTIGFAI

Rat                           EEDDDPDDSEVICSFLVALMQKNRRKDRKLGANLFTIGFAI

Pig                           EEDDDPDDSEVICSFLVALMQKNRRKDRKLGANLFTIGFAI

Bovine                        EEDDDPDDSEVICSFLVALMQKNRRKDRKLGANLFTIGFAI

Sheep                         EEDDDPDDSEVICSFLVALMQKNRRKDRKLGANLFTIGFAI

Chicken                       EEDDDPEDEEVICSFLVALMQKNRRKERKLGANLYTIGFAI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 821 Calpain-3
Region 418 – 586 Domain III
Alternative sequence 1 – 665 Missing. In isoform V.
Alternative sequence 1 – 512 Missing. In isoform IV.


Literature citations

Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain).
Urtasun M.; Saenz A.; Roudaut C.; Poza J.J.; Urtizberea J.A.; Cobo A.-M.; Richard I.; Garcia Bragado F.; Leturcq F.; Kaplan J.-C.; Marti Masso J.F.; Beckmann J.S.; Lopez de Munain A.;
Brain 121:1735-1747(1998)
Cited for: VARIANTS LGMDR1 ARG-222; GLU-486; TRP-489 AND GLN-748;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.